Advertisement

Topics

Companies Related to "Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease" [Most Relevant Company Matches] RSS

10:01 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Study Evaluate Cinacalcet Pediatric Subjects With Chronic Kidney" Companies 1–25 of 1,800+

Extremely Relevant

Sensipar® (cinacalcet HCl)

Sensipar® (cinacalcet HCl) is an innovative, first-in-class, oral therapy indicated to treat hyperparathyroidism (excessive levels of parathyroid hormone) caused by chronic kidney disease; it is approved for use in patients who are receiving dialysis. It is also indicated to treat elevated calcium levels in patients with malignant tumors of the parathyroid gland.


Relevant

PharmaTech Solutions Inc

PTS was founded in 1999 by a group of pharmaceutical research professionals who believed that a pioneering approach was required to solve the industry’s study enrollment problems. Through innovation and excellence, PTS has amassed the technology and experience to develop patient recruitment solutions that identify and address the core issues that can hinder enrollment. PTS understands that findi...

The Kidney TRUST

Founded in 2006, the TRUST is a non-profit organization dedicated to reducing the human and economic cost of kidney disease. The TRUST is focused on increasing awareness of chronic kidney disease (CKD) through public education and testing programs so that progression of CKD to kidney failure can be delayed or prevented. The TRUST is also developing innovative solutions to address the critical un...


Thrasos Therapeutics

Thrasos TherapeuticsTM is a private, clinical stage, biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. The Company is advancing therapeutic programs, led by THR-184, for renal diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD). Thrasos’...

Patient Engagement Systems® (PES)

Patient Engagement Systems® (PES) is a nationally recognized healthcare services company dedicated to supporting its customers’ goal of helping people with chronic diseases, specifically diabetes and chronic kidney disease, improve their health, and reduce costs related to inpatient admissions and ER visits. PES provides medical groups, IPAs, health ...

Patient Engagement Systems

Patient Engagement Systems® (PES) is a nationally recognized healthcare services company dedicated to supporting its customers’ goal of helping people with chronic diseases, specifically diabetes and chronic kidney disease, improve their health, and reduce costs related to inpatient admissions and ER visits. PES provides medical groups, IPAs, health ...

CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the h...

Kibow Biotech Inc

Kibow Biotech Inc. was founded in 1997 by Dr. N. Ranganathan and Dr. Jack Dickstein. Kibow Biotech Inc. started out to fill the void in treatments for patients with chronic kidney disease. Since then Kibow Biotech Inc. has been actively researching on ways and methods to develop a cost-effective non-invasive treatment for kidney disease patients. This has since became our mission statement. The co...

Thrasos, Inc.

Thrasos is a private, clinical stage, bio-therapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease. The Company has advanced two compounds, THR-184 and THR-123, into development for Acute Kidney Injury (AKI) and Chronic Kidney Injury (CKD), respectively, and initiated Phase 1 cli...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

International Pharmaceutical Research Center

International Pharmaceutical Research Center the commitment to unparalleled Quality Research. Our strength is our recognition from sponsors, investigators, and study subjects in conducting each study with dedication and a personal touch, while maintaining strict compliance with good clinical practice.

National Kidney Foundation

The National Kidney Foundation, with offices throughout the country, is dedicated to preventing and treating kidney and urinary tract diseases, improving the health and well being of individuals and families affected by these diseases and increasing availability of all organs for transplantation. More at www.kidney.org.

Fibrotech Therapeutics

Fibrotech is an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis (tissue scarring). The Company develops novel anti-fibrotic drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as chronic kidney disease, chronic heart failure, pulmonary fibros...

nTouch Research Corporation

nTouch Research Corporation is a leading provider of Phase II-IV clinical trials services delivering investigator selection, patient recruitment and study management services for pharmaceutical, CRO, and biotechnology industries.nTouch owns and operates 16 highly-rated research centers across the USA serving 250 private practice investigators. Our strength is our commitment to sponsors, investigat...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

Kidney Research UK

Kidney disease is not, as commonly thought, a disease that affects only the elderly - it can happen at any age. Treatment options include a transplant - for which there is a waiting list or a life on dialysis, a life sustaining treatment - but which can severely restrict daily life.Founded in 1961, Kidney Research UK is the leading UK charity funding research that focuses on the prevention, treatm...

Texas Children's Hospital

Texas Children's Hospital runs an active transplantation program in heart, lungs, liver, kidney and bone morrow for pediatric patients. In 1984, Dr. Denton A. Cooley performed the first pediatric heart transplant on a 9-month-old female patient. She lived to be 13 years old. Since that time, the heart transplant program has grown into one of the largest and most successful program of its kind in t...

NephroGenex, Inc.

NephroGenex (www.nephrogenex.com) is a drug development company focusing on kidney disease. More than 20 million Americans have some form of chronic kidney disease, and over 400,000 in the US have end stage renal disease requiring dialysis, making renal disease one of the costliest illnesses to treat. The Company is developing Pyridorin(TM) (pyridoxamine dihydrochloride) as a treatment to slow t...

Ario Pharma Ltd

ario pharma ltd focusses on the development of drugs for the treatment of respiratory indications. Ario is about to evaluate the anti-tussive properties of XEN-D0501, a potential best-in-class TRPV1 inhibitor, in two Phase 2 clinical trials that will read out in 2014. The company is managed by a highly experienced development team and supported by world-renowned KOLs in respiratory disease. Co...

Ortho Biotech

In 1990, Ortho Biotech was established as the first biotechnology subsidiary of Johnson & Johnson.Today, our products and treatments combat some of the most serious diseases - such as cancer, HIV/AIDS, and chronic kidney disease. They also help restore the health and comfort of patients undergoing elective surgery, organ transplants, and chemotherapy.We are a leader in the worldwide treatment of a...

Satellite Healthcare, Inc. Satellite Healthcare

Satellite Healthcare, Inc., founded in 1974, is one of the nation's first not-for-profit providers of dialysis services and kidney disease care. With its expanded offerings Satellite Healthcare provides early patient wellness education, personalized clinical services and a complete range of dialysis therapy choices. This comprehensive offering allows Satel...

Roskilde University

Roskilde University is a state university founded in 1972 with the objective of providing research and education at the highest level in the fields of natural science, social science and the humanities. These activities at Roskilde University are organised in ten departments; degrees are offered in a wide range of subjects at Bachelor, Master and Ph.D. levels.Many study programmes are now being of...

CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications, in effect, tr...

DaVita Labs

DaVita Labs, a division operating within DaVita Inc., provides quality, on-time, accurate results to help effectively identify and manage kidney patients across the nation. As a cutting-edge chronic kidney disease (CKD) specialty laboratory, DaVita Labs features the latest in end stage renal disease-specific methodology and technology for delivering quality ...

Satellite Healthcare, Inc.

Satellite Healthcare, Inc. is one of the nation's first and leading providers of dialysis services and kidney disease care. With its affiliated services - Satellite WellBound, Satellite Dialysis and Satellite Research, Satellite Healthcare provides early patient wellness education, personalized clinical services and a complete range of dialysis therapy choices. This comprehensive offering allows S...


More From BioPortfolio on "Study to Evaluate Cinacalcet HCl in Pediatric Subjects With Chronic Kidney Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks